Clinical trial

Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer

NCT04192331

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-02-21

PhasePHASE2

Study timeline

Study start (actual)2019-02-21Date precision: day

Registry last updated2022-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

nab-paclitaxel regimen1DRUG

nab-paclitaxel regimen2DRUG

Sponsors & collaborators

Peking University Cancer Hospital & Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04192331 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.